Bank of New York Mellon Corp - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 62 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2019$1,030,000
+0.4%
900,0000.0%0.00%
Q3 2019$1,026,000
-3.9%
900,0000.0%0.00%
Q2 2019$1,068,000
-12.2%
900,0000.0%0.00%
Q1 2019$1,217,000
+182.4%
900,000
+125.0%
0.00%
Q4 2018$431,000
-54.5%
400,000
-55.6%
0.00%
Q3 2018$947,000
+7.4%
900,0000.0%0.00%
Q2 2018$882,000
-25.9%
900,000
-25.0%
0.00%
Q1 2018$1,190,000
-6.0%
1,200,0000.0%0.00%
Q4 2017$1,266,000
-0.5%
1,200,0000.0%0.00%
Q3 2017$1,273,000
+0.1%
1,200,0000.0%0.00%
Q2 2017$1,272,000
+10.2%
1,200,0000.0%0.00%
Q1 2017$1,154,000
-17.3%
1,200,000
-11.1%
0.00%
Q4 2016$1,395,000
+232.1%
1,350,000
+200.0%
0.00%
Q3 2016$420,000
+32.5%
450,0000.0%0.00%
Q2 2016$317,000
-65.2%
450,000
-55.0%
0.00%
Q1 2016$910,000
-18.0%
1,000,0000.0%0.00%
Q4 2015$1,110,0001,000,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2019
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders